bridgebio oncology
PrivateLast Round
VC Round
May 2, 2024
Last Round Size
$200M
Total Funding Raised
$1.4B
Company Overview
BridgeBio Oncology Therapeutics is a biopharmaceutical company focused on developing small molecule therapeutics to treat genetic diseases and cancers, particularly targeting RAS and PI3K malignancies to enhance treatment outcomes for patients.
Sector
Biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
bridgebio oncology Comps
Related companies by embedding similarity.
bridgebio oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 2, 2024 | ||||
| Follow-on Offering | Jul 24, 2023 | ||||
| Debt | Nov 2, 2022 | ||||
| Convertible Debt | Mar 11, 2021 | ||||
| Convertible Debt | Jan 29, 2020 | ||||
IPO Announced | Jun 27, 2019 |
bridgebio oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about bridgebio oncology's valuation, stock price, and market status.
